Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
June 17 2019 - 4:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF
DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number:
001-38217
Nightstar
Therapeutics plc
(Exact name of registrant as specified in its charter)
10 Midford Place, 2
nd
Floor
London, United Kingdom W1T 5BJ
+44 20 7062 2777
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
American Depository Shares, each representing one Ordinary share, nominal value £0.01 per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an
X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule
12g-4(a)(1)
|
|
☒
|
Rule
12g-4(a)(2)
|
|
☐
|
Rule
12h-3(b)(1)(i)
|
|
☒
|
Rule
12h-3(b)(1)(ii)
|
|
☐
|
Rule
15d-6
|
|
☐
|
Approximate number of holders of record as of the certification or notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Nightstar Therapeutics
plc has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
NIGHTSTAR THERAPEUTICS PLC
|
|
|
|
|
Date: June 17, 2019
|
|
|
|
By:
|
|
/s/ Steven Green
|
|
|
|
|
Name:
|
|
Steven Green
|
|
|
|
|
Title:
|
|
Director
|
[Signature Page to Form 15]
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Apr 2023 to Apr 2024